Drug: EVP-6124

DRUG2 trials

Sponsors

FORUM Pharmaceuticals Inc

Conditions

Alzheimer's DiseaseDementia

Phase 3

Study of the Safety and Effectiveness of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease

TerminatedNCT01969136

FORUM Pharmaceuticals IncAlzheimer's Disease, Dementia

Start: 2013-10-31End: 2017-01-31Updated: 2016-05-03

Study of the Safety and Effectiveness of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease

TerminatedNCT01969123

FORUM Pharmaceuticals IncAlzheimer's Disease, Dementia

Start: 2013-10-31End: 2017-01-31Updated: 2016-05-03

Related Papers

ABT-126 monotherapy in mild-to-moderate Alzheimer's dementia: randomized double-blind, placebo and active controlled adaptive trial and open-label extension.

2016-10-1831 citations

A phase 2 randomized, controlled trial of the α7 agonist ABT‐126 in mild‐to‐moderate Alzheimer's dementia

Alzheimer s & Dementia Translational Research & Clinical Interventions2015-06-0139 citations